Additional file 1 of Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high levels of endotoxemia: the ENDoX bicentric, randomized, controlled trial

Additional file 1: Annex S1. Vasopressor Dependency Index, oXiris Haemodialysis Settings and Anticoagulation Strategy. Annex S2. Rationale for the use of the Endotoxin Activity Assay. Table S1. Extended Baseline and Population Characteristics. Table S2. Extended Inflammation Biomarkers. Table S3. SOFA Score, Lactate levels and Vasopressor Index over time. Table S4. Extended Hemodynamic Parameters and PaO2/ FiO2 Ratio. Figure S1. Mortality at 28 Days in All patients stratified by Intervention Arm. Table S5. Reported AEs & SAEs

Additional file 1 of Microcirculatory alterations in critically ill COVID-19 patients analyzed using artificial intelligence

Additional file 1. Supplementary information

Additional file 1 of Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registry

Additional file 1. Online Supplementary Material